U.S. drug regulators should not delay in authorizing COVID-19 vaccines for young children, a top Democrat said on April 25.
Rep. Jim Clyburn (D-S.C.) asked Food and Drug Administration (FDA) Commissioner Robert Califf whether reports that the FDA is considering postponing a decision on whether to clear Moderna’s jab so that it can be reviewed at the same time as Pfizer’s shot are accurate.
